Trial Profile
Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP+FF) by Modulite upon Exhaled Nitric Oxide in asthma FENOMENO Study (Fractional Exhaled Nitric Oxide Multiple Expiration flow of eNO) A single-center, placebo controlled, randomized, double-blind, two-way cross-over study.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2011
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma
- Focus Biomarker; Therapeutic Use
- Acronyms FENOMENO
- 21 Jul 2011 New trial record